RIPA-56
RIPA-56 is a highly potent, selective, and metabolically stable inhibitor of receptor-interacting protein 1 (RIP1) with an IC50 of 13 nM. RIPA-56 can be used for the treatment of systemic inflammatory response syndrome[1].
Product Specifications
CAS Number
1956370-21-0
UNSPSC
12352005
Hazard Statement
H302, H312, H315, H319
Target
RIP kinase
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/RIPA-56.html
Purity
99.94
Solubility
DMSO : ≥ 100 mg/mL
Smiles
CCC(C)(C)C(N(CC1=CC=CC=C1)O)=O
Molecular Formula
C13H19NO2
Molecular Weight
221.30
Precautions
H302, H312, H315, H319
References & Citations
[1]Ren Y, et al. Discovery of a Highly Potent, Selective, and Metabolically Stable Inhibitor of Receptor-InteractingProtein 1 (RIP1) for the Treatment of Systemic Inflammatory Response Syndrome. J Med Chem. 2017 Feb 9;60 (3) :972-986.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR10448569 96 Well
Mouse Complement C1s subcomponent (C1S) ELISA kit
Sign In for Pricing
View Details 
PGC25A-50 50 Tests
MODIfinder Real-Time PCR GM Corn MON87427 detection kit (UID MON-87427-7)
Sign In for Pricing
View Details 